Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Clinical trial NCT00973804 · TERMINATED

Trial details

NCT number

NCT00973804

Sponsor

National Cancer Institute (NCI)

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2009-08-25

Primary completion

2013-05-20

Enrollment

4

View on ClinicalTrials.gov